Dr. Georgios Kremastiotis
Education
| 2018-2022 | BHF PhD in Translational Health Sciences, University of Bristol |
| 2016-2018 | MSc in Pharmacology, University of Athens |
| 2010-2016 | BSc in Pharmacy, University of Athens |
Present Appointment
| 2024- | Research Associate National Heart and Lung Institute Imperial College London London, UK |
Previous Appointment
| 2024 | Research Associate Translational Health Sciences, Bristol Medical School, University of Bristol |
| 2022-2024 | BHF Accelerator Award Transition Fellow Translational Health Sciences, Bristol Medical School, University of Bristol |
Publications
| 1 | Kremastiotis G, Handa I, Jackson C, George S, Johnson J. Disparate effects of MMP and TIMP modulation on coronary atherosclerosis and associated myocardial fibrosis. Scientific Reports. 2021 11(1) : 23081. [Full Text] [PubMed] [DOI] |
| 2 | Efentakis P, Kremastiotis G, Varela A, Nikolaou P E, Papanagnou E D, Davos C H, Tsoumani M, Agrogiannis G, Konstantinidou A, Kastritis E, Kanaki Z, Iliodromitis E K, Klinakis A, Dimopoulos M A, Trougakos I P, Andreadou I, Terpos E. Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin. Blood. 2019 133(7) : 710-723. [Full Text] [PubMed] [DOI] |